Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Phase 2 Trial

Recent news which mentions Phase 2 Trial

< Previous 1 2 3 4 5 6 7 8 9 Next >
BiomX's Acne Vulgaris Treatment Fails To Top Vehicle Treatment Cohort
Tickers PHGE
Tags Acne Vulgaris General Movers
From Benzinga
Vertex Unveils First Patient Results On Potential Diabetes Treatment
Tickers VRTX
Tags News Type I Diabetes VRTX
From Benzinga
Regenxbio Reveals Interim Data From Diabetic Retinopathy Gene Therapy Trial
Tickers RGNX
Tags RGNX General Small Cap
From Benzinga
Bristol Myers' TYK2 Inhibitor Disappoints In Mid-Stage Ulcerative Colitis Study
Tickers BMY
Tags Briefs News Trading Ideas
From Benzinga
Denali Highlights Encouraging Early Data, Update For Amyotrophic Lateral Sclerosis Program
Tickers DNLI SNY
Tags General DNLI News
From Benzinga
Entera Bio's Formulated Human Parathyroid Hormone Shows Encouraging BMD Data
Tickers ENTX
Tags General Penny Stocks osteoporosis
From Benzinga
Vaxart Starts Recruitment In Mid-Stage COVID-19 Oral Vaccine Trial
Tickers VXRT
Tags VXRT COVID/19 Coronavirus Small Cap
From Benzinga
Takeda Discontinues Two Mid-Stage Narcolepsy Trials
Tickers TAK TKPHF
Tags General TAK Briefs
From Benzinga
Why Did Kaleido Shares Plunge 10% On Tuesday?
Tickers KLDO
Tags Movers General ulcerative colitis
From Benzinga
Gemini Axes Chief Scientific Officer, 20% Of Staff To Focus On Geographic Atrophy Candidate
Tickers GMTX
Tags Penny Stocks General News
From Benzinga
EXCLUSIVE: Annovis Bio's Parkinson's Candidate Improves Speed, Motor Function Vs Placebo
Tickers ANVS
Tags General Parkinson’s Disease News
From Benzinga
Why Did RedHill Biopharma Shares Jump 12% Monday?
Tickers RDHL
Tags Health Care Benzinga Biotech
From Benzinga
Enanta To Discontinue Internal Development Of NASH Candidates
Tickers ENTA
Tags Health Care Benzinga Biotech
From Benzinga
AnaptysBio Reveals Updated Imsidolimab Data In Severe Form Of Psoriasis
Tickers ANAB
Tags General Small Cap Phase 2 Trial
From Benzinga
CTI BioPharma's COVID-19 Candidate Misses Primary Endpoint Mark In Phase 2 Trial
Tickers CTIC
Tags Phase 2 Trial Market News Biotech
From Benzinga
Xenon Pharma Shares Jump After Epilepsy Treatment Phase 2 Data Meets Primary Endpoint
Tickers XENE
Tags Long Ideas XENE General
From Benzinga
J&J's RSV Vaccine Candidate Shows 80% Efficacy In Older Adults
Tickers JNJ
Tags News Health Care Biotech
From Benzinga
Eli Lilly's Mirikizumab Maintains Symptomatic Remission for Two Years In Ulcerative Colitis Patients
Tickers LLY
Tags Phase 2 Trial Market News Benzinga
From Benzinga
Precigen Posts Additional Interim Data From Type 1 Diabetes Trial
Tickers PGEN PRVB
Tags Phase 1 Trial Small Cap Health Care
From Benzinga
BioNTech Starts Dosing In Mid-Stage Colorectal Cancer Immunotherapy Trial
Tickers BNTX RHHBF RHHBY RHHVF
Tags RHHBY RHHVF Benzinga
From Benzinga
Minerva Posts Positive Bioequivalence Results For Schizophrenia Candidate Formulations
Tickers NERV
Tags Penny Stocks General Movers
From Benzinga
AIM ImmunoTech Recruits hVIVO For Ampligen Trial For Prophylaxis Use Against Respiratory Viruses
Tickers AIM
Tags Phase 2 Trial Market News News
From Benzinga
Regeneron-Roche Post Encouraging New Data For COVID-19 Antibody Cocktail
Tickers REGN RHHBF RHHBY RHHVF
Tags REGN General RHHBF
From Benzinga
Here's Why Editas Stock Dropped After Data From CRISPR-Based Retinal Disorder Candidate
Tickers EDIT
Tags Trading Ideas why it's moving Briefs
From Benzinga
Adagio's COVID-19 Candidate Shows Prolonged Half-Life, Neutralization At Six Months
Tickers ADGI AZN AZNCF MRNA
Tags Phase 2 Trial Market News Benzinga
From Benzinga
Graybug Vision Posts Six-Month Extension GB-102 Data Of Wet AMD Trial
Tickers GRAY REGN
Tags Biotech Benzinga GRAY
From Benzinga
Why Are I-Mab Shares Trading Higher On Tuesday?
Tickers IMAB MGNX MRK
Tags News Briefs why it's moving
From Benzinga
Valneva, Pfizer Lyme Disease Vaccine Candidate Drops-Off After 18 Months
Tickers PFE VALN
Tags Market News Phase 2 Trial Health Care
From Benzinga
Ultragenyx Resumes Dosing Antisense Trial In Rare Neurogenetic Disorder
Tickers RARE
Tags Phase 1 Trial Angelman syndrome Health Care
From Benzinga
Pfizer Kick Starts Late-Stage Study For COVID-19 Oral Antiviral For Post-Exposure Prophylaxis
Tickers PFE
Tags PFE General News
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.